Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Karin Samuelsson. (1971) Identification and Quantitative Determination of Ceramides in Human Plasma. Scandinavian Journal of Clinical and Laboratory Investigation 27:4, pages 371-380.
Read now
Read now
Articles from other publishers (36)
Annie Kleynerman, Jitka Rybova, Mary L. Faber, William M. McKillop, Thierry Levade & Jeffrey A. Medin. (2023) Acid Ceramidase Deficiency: Bridging Gaps between Clinical Presentation, Mouse Models, and Future Therapeutic Interventions. Biomolecules 13:2, pages 274.
Crossref
Crossref
Catherine Meyer-Schwesinger. (2021) Lysosome function in glomerular health and disease. Cell and Tissue Research 385:2, pages 371-392.
Crossref
Crossref
Kalia Kyriakou, Carsten W. Lederer, Marina Kleanthous, Anthi Drousiotou & Anna Malekkou. (2020) Acid Ceramidase Depletion Impairs Neuronal Survival and Induces Morphological Defects in Neurites Associated with Altered Gene Transcription and Sphingolipid Content. International Journal of Molecular Sciences 21:5, pages 1607.
Crossref
Crossref
Michael Beck, Hugo W. Moser & Konrad Sandhoff. 2020. Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease. Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease
547
557
.
Fabian P.S. Yu, Salvatore Molino, Jakub Sikora, Shauna Rasmussen, Jitka Rybova, Everett Tate, Aron M. Geurts, Patricia V. Turner, William M. Mckillop & Jeffrey A. Medin. (2019) Hepatic pathology and altered gene transcription in a murine model of acid ceramidase deficiency. Laboratory Investigation 99:10, pages 1572-1592.
Crossref
Crossref
Fabian P. S. Yu, Samuel Amintas, Thierry Levade & Jeffrey A. Medin. (2018) Acid ceramidase deficiency: Farber disease and SMA-PME. Orphanet Journal of Rare Diseases 13:1.
Crossref
Crossref
Fabian P. S. Yu, Diana Islam, Jakub Sikora, Shaalee Dworski, Jiří Gurka, Lucía López-Vásquez, Mingyao Liu, Wolfgang M. Kuebler, Thierry Levade, Haibo Zhang & Jeffrey A. Medin. (2018) Chronic lung injury and impaired pulmonary function in a mouse model of acid ceramidase deficiency. American Journal of Physiology-Lung Cellular and Molecular Physiology 314:3, pages L406-L420.
Crossref
Crossref
Anuradha Ganesh, Fathiya Al-Murshedi, Sana Al-Zuhaibi & Khalid Al-Thihli. 2017. The Eye in Pediatric Systemic Disease. The Eye in Pediatric Systemic Disease
359
460
.
Michael Beck, Hugo W. Moser & Konrad Sandhoff. 2015. Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease. Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease
395
402
.
E. Ellen Jones, Shaalee Dworski, Daniel Canals, Josefina Casas, Gemma Fabrias, Drew Schoenling, Thierry Levade, Chadrick Denlinger, Yusuf A. Hannun, Jeffrey A. Medin & Richard R. Drake. (2014) On-Tissue Localization of Ceramides and Other Sphingolipids by MALDI Mass Spectrometry Imaging. Analytical Chemistry 86:16, pages 8303-8311.
Crossref
Crossref
Sandra Merscher & Alessia Fornoni. (2014) Podocyte Pathology and Nephropathy – Sphingolipids in Glomerular Diseases. Frontiers in Endocrinology 5.
Crossref
Crossref
Jie Zhou, Marcel Tawk, Francesco Danilo Tiziano, Julien Veillet, Monica Bayes, Flora Nolent, Virginie Garcia, Serenella Servidei, Enrico Bertini, Francesc Castro-Giner, Yavuz Renda, Stéphane Carpentier, Nathalie Andrieu-Abadie, Ivo Gut, Thierry Levade, Haluk Topaloglu & Judith Melki. (2012) Spinal Muscular Atrophy Associated with Progressive Myoclonic Epilepsy Is Caused by Mutations in ASAH1. The American Journal of Human Genetics 91:1, pages 5-14.
Crossref
Crossref
Junko Matsuda, Makiko Kido, Keiko Tadano-Aritomi, Ineo Ishizuka, Kumiko Tominaga, Kazunori Toida, Eiji Takeda, Kunihiko Suzuki & Yasuhiro Kuroda. (2004) Mutation in saposin D domain of sphingolipid activator protein gene causes urinary system defects and cerebellar Purkinje cell degeneration with accumulation of hydroxy fatty acid-containing ceramide in mouse. Human Molecular Genetics 13:21, pages 2709-2723.
Crossref
Crossref
AM Yeager, K Armfield Uhas, CD Coles, PC Davis, WL Krause & HW Moser. (2000) Bone marrow transplantation for infantile ceramidase deficiency (Farber disease). Bone Marrow Transplantation 26:3, pages 357-363.
Crossref
Crossref
A. Fiumara, F. Nigro, L. Pavone & H. W. Moser. (1993) Farber disease with prolonged survival. Journal of Inherited Metabolic Disease 16:5, pages 915-916.
Crossref
Crossref
Takehisa Fujiwaki, Sumiko Hamanaka, Mayumi Koga, Tokuhiro Ishihara, Ryuuta Nishikomori, Eiichi Kinoshita & Kenshi Furusho. (2007) A Case of Farber Disease. Pediatrics International 34:1, pages 72-79.
Crossref
Crossref
Y. Ben-Yoseph, R. Gagné, M. R. Parvathy, D. A. Mitchell & T. Momoi. (2008) Leukocyte and plasma N-laurylsphingosine deacylase (ceramidase) in Farber disease. Clinical Genetics 36:1, pages 38-42.
Crossref
Crossref
Stephen J. Qualman, Hugo W. Moser, David Valle, Anne E. Moser, Stylianos E. Antonarakis, John K. Boitnott, William H Zinkham, John M. Opitz & Jay Bernstein. (1987) Farber Disease: Pathologic diagnosis in sibs with phenotypic variability. American Journal of Medical Genetics 28:S3, pages 233-241.
Crossref
Crossref
J. F. Pellissier, M. Berard-Badier & N. Pinsard. (1986) Farber's disease in two siblings, sural nerve and subcutaneous biopsies by light and electron microscopy. Acta Neuropathologica 72:2, pages 178-188.
Crossref
Crossref
U. Burck, H. W. Moser, H. H. Goebel, R. Gr�ttner & K. R. Held. (1985) A case of lipogranulomatosis Farber: some clinical and ultrastructural aspects. European Journal of Pediatrics 143:3, pages 203-208.
Crossref
Crossref
Julian N. Kanfer & Sen-itiroh HakomoriJulian N. Kanfer. 1983. Sphingolipid Biochemistry. Sphingolipid Biochemistry
249
325
.
Winston W. Chen, Ann B. Moser & Hugo W. Moser. (1981) Role of lysosomal acid ceramidase in the metabolism of ceramide in human skin fibroblasts. Archives of Biochemistry and Biophysics 208:2, pages 444-455.
Crossref
Crossref
Christian Schmoeckel & Michael Hohlfed. (1979) A specific ultrastructural marker for disseminated lipogranulomatosis (Farber). Archives of Dermatological Research 266:2, pages 187-196.
Crossref
Crossref
Daniel Bergsma. 1979. Birth Defects Compendium. Birth Defects Compendium
23
1089
.
M. TOPPET, E. VAMOS‐HURWITZ, G. JONNIAUX, N. CREMER, M. TONDEUR & S. PELC. (2008) FARBER'S DISEASE AS A CERAMIDOSIS: CLINICAL, RADIOLOGICAL AND BIOCHEMICAL ASPECTS. Acta Paediatrica 67:1, pages 113-119.
Crossref
Crossref
G. H. Amirhakimi, Parviz Haghighi, M. A. Ghalambor & S. Honari. (2008) Familial Lipogranulomatosis (Farber's disease). Clinical Genetics 9:6, pages 625-630.
Crossref
Crossref
John Dulaney, Hugo W. Moser, James Sidbury & Aubrey Milunsky. 1976. Current Trends in Sphingolipidoses and Allied Disorders. Current Trends in Sphingolipidoses and Allied Disorders
403
411
.
Mutsumi Sugita, Masao Iwamori, James Evans, Robert H. McCluer, John T. Dulaney & Hugo W. Moser. (1974) High performance liquid chromatography of ceramides: application to analysis in human tissues and demonstration of ceramide excess in Farber's disease. Journal of Lipid Research 15:3, pages 223-226.
Crossref
Crossref
C.V. Viswanathan. (1974) Coupled gas chromatography—mass spectrometry in the separation and characterization of polar lipids. Journal of Chromatography A 98:1, pages 105-128.
Crossref
Crossref
K.-A. Karlsson, B.E. Samuelsson, T. Scherstén, G.O. Steen & L. Wahlqvist. (1974) The sphingolipid composition of human renal carcinoma. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism 337:3, pages 349-355.
Crossref
Crossref
M. Sugita, P. Connolly, J. T. Dulaney & H. W. Moser. (1973) Fatty acid composition of free ceramides of kidney and cerebellum from a patient with Farber's disease. Lipids 8:7, pages 401-406.
Crossref
Crossref
Kunihiko Suzuki & Kinuko Suzuki. 1974. Biology of Brain Dysfunction. Biology of Brain Dysfunction
1
73
.
Mutsumi Sugita, John T. Dulaney & Hugo W. Moser. (1972) Ceramidase Deficiency in Farber's Disease (Lipogranulomatosis). Science 178:4065, pages 1100-1102.
Crossref
Crossref
B. Gerstl, M. G. Tavaststjerna, L. F. Eng & J. K. Smith. (1972) Sphingolipids and their precursors in human brain (Normal and MS). Zeitschrift f�r Neurologie 202:2, pages 104-120.
Crossref
Crossref
K. Samuelsson, R. Zetterström & B. I. Ivemark. 1972. Sphingolipids, Sphingolipidoses and Allied Disorders. Sphingolipids, Sphingolipidoses and Allied Disorders
533
548
.
Sven Hammarström. (1971) A convenient procedure for the synthesis of ceramides. Journal of Lipid Research 12:6, pages 760-765.
Crossref
Crossref